Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
Tue, 05/30/17 - 11:35 am
Tags:
ASCO 2017, Merck, AbbVie, Eli Lilly, Bluebird Bio, Epizyme, Juno Therapeutics, Kite, Merus
bluebird bio Updates, Investors Wait
Motley Fool
Sun, 05/7/17 - 10:15 am
Tags:
Bluebird Bio, earnings
Biotechs Breaking Out On Drug Development News
Forbes
Fri, 03/3/17 - 09:21 am
Tags:
Bluebird Bio, Esperion Therapeutics, Amicus Therapeutics, Kite Pharma
Four biotech stocks surging on optimism about drug trials, product launches
Marketwatch
Thu, 03/2/17 - 03:43 pm
Tags:
clinical trials, Bluebird Bio, Amicus Therapeutics, Kite Pharma, NeuroDerm
Bluebird Bio 4Q Loss Below Street Estimates
Investopedia
Thu, 02/23/17 - 09:29 pm
Tags:
Bluebird Bio, earnings
Why bluebird bio Stock Surged 20.7% Higher in January
Motley Fool
Thu, 02/9/17 - 09:27 pm
Tags:
Bluebird Bio, Lenti-D
Twittering And Other Thoughts About bluebird bio
Seeking Alpha
Tue, 12/27/16 - 10:23 am
Tags:
Bluebird Bio
Bluebird bio stock gains on impressive early cancer trial results
Bizjournals.com
Thu, 12/1/16 - 09:53 am
Tags:
Bluebird Bio, clinical trials, bb2121, Multiple Myeloma
5 Biotech IPOs Lead The Way In 2016
Seeking Alpha
Mon, 11/28/16 - 09:51 am
Tags:
biotech, IPOs, AveXis, Clearside Biomedical, Protagonist Therapeutics, Reata Pharmaceuticals, Bluebird Bio
Bluebird Bio 3Q Loss $2.07/Shr Below Street
Investopedia
Mon, 11/7/16 - 09:12 am
Tags:
Bluebird Bio, earnings
Bluebird touts upgrades to gene therapy, but shares slip
BioPharma Dive
Mon, 10/17/16 - 11:44 am
Tags:
Bluebird Bio, gene therapy, LentiGlobin
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
Tags:
biotech, Eli Lilly, solanezumab, Biogen, aducanumab, Kite Pharma, KTE-C19, Bluebird Bio, LentiGlobin, Sarepta Therapeutics, eteplirsen, Ophthotech, Fovista, Bristol-Myers Squibb, Opdvio, Acadia, Nuplazid, Celgene, GED-301, Gilead Sciences, M&A
Bluebird bio adds a key process to pioneering gene therapy as it ramps up a pivotal PhIII
Endpoints
Thu, 09/8/16 - 06:28 pm
Tags:
Bluebird Bio, gene therapy, LentiGlobin
Could Toxicity Issues Topple CAR-T Cancer Therapies?
Motley Fool
Sun, 08/28/16 - 10:09 am
Tags:
CAR-T, clinical trials, Juno Therapeutics, Kite Pharma, Bluebird Bio, Ziopharma Oncology
Juno Throws Down The Multiple Myeloma Gauntlet To Bluebird
Seeking Alpha
Tue, 08/9/16 - 10:54 pm
Tags:
Juno Therapeutics, Multiple Myeloma, Bluebird Bio, CAR-T
Juno strikes deal to join bluebird, Novartis in busy multiple myeloma niche
Fierce Biotech
Sat, 08/6/16 - 01:19 pm
Tags:
Juno Therapeutics, Bluebird Bio, Novartis, Multiple Myeloma, BCMA
Can Bluebird Bio Fly Again?
Seeking Alpha
Wed, 05/18/16 - 11:14 am
Tags:
Bluebird Bio, gene therapy
bluebird bio Inc: Catnapping in Cambridge
Motley Fool
Fri, 05/13/16 - 10:20 am
Tags:
Bluebird Bio, earnings
bluebird bio, Inc. Takes Flight Towards First Approval
Motley Fool
Thu, 04/21/16 - 10:05 am
Tags:
Bluebird Bio, FDA, CCALD, Lenti-D
Why bluebird bio's Stock Jumped 12.9% on Wednesday
Motley Fool
Thu, 04/7/16 - 09:39 am
Tags:
Bluebird Bio

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.